Detalhe da pesquisa
1.
Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer.
J Urol
; 211(3): 376-383, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38329047
2.
PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
Prostate
; 83(10): 922-928, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078628
3.
Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
J Urol
; 210(2): 281-289, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099018
4.
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort.
J Urol
; 209(1): 198-207, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36067374
5.
Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
J Urol
; 207(4): 832-840, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854749
6.
The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer.
J Urol
; 207(5): 1001-1009, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981949
7.
Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort.
Prostate
; 81(13): 1009-1017, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288004
8.
Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer.
Prostate
; 81(2): 102-108, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33075151
9.
The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?
J Urol
; 205(1): 109-114, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198555
10.
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen.
J Urol
; 206(3): 706-714, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905262
11.
Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database.
World J Urol
; 39(6): 1911-1916, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737581
12.
Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality.
Curr Oncol Rep
; 23(3): 37, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689041
13.
The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
J Urol
; 204(6): 1222-1228, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33157570
14.
Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer.
J Urol
; 204(6): 1216-1221, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519915
15.
MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort.
AJR Am J Roentgenol
; 214(3): 574-578, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913068
16.
Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer Database.
BMC Urol
; 20(1): 103, 2020 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32680507
17.
A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database.
BMC Urol
; 20(1): 40, 2020 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303266
18.
Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer.
J Urol
; 202(4): 696-701, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958742
19.
Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
Curr Opin Urol
; 29(6): 605-611, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436567
20.
Urologists in Advocacy: The Key to Addressing Disparities in Prostate Cancer.
J Urol
; 209(1): 27-28, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394976